Jacques Tapiero
Direktor/Vorstandsmitglied bei MCCORMICK & COMPANY, INCORPORATED
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Jacques Tapiero
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MCCORMICK & COMPANY, INCORPORATED | Direktor/Vorstandsmitglied | 24.09.2012 | - |
| Independent Dir/Board Member | 24.09.2012 | - | |
| Thunderbird School of Global Management | Corporate Officer/Principal | 05.05.2011 | - |
Esteve Pharmaceuticals S.A.
 Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Direktor/Vorstandsmitglied | - | - |
Esteve Healthcare SL
 Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019. | Direktor/Vorstandsmitglied | 01.12.2016 | - |
Karriereverlauf von Jacques Tapiero
Ehemalige bekannte Positionen von Jacques Tapiero
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.1983 | 31.01.2014 |
Lilly France SAS
 Lilly France SAS Pharmaceuticals: GenericHealth Technology Lilly France SAS manufactures and supplies therapeutic products. The company is headquartered in Neuilly-sur-Seine, France. | Vorstandsvorsitzender | 01.01.2000 | 01.01.2004 |
| Präsident | 01.01.2000 | - | |
Eli Lilly do Brasil Ltda.
 Eli Lilly do Brasil Ltda. Pharmaceuticals: MajorHealth Technology Eli Lilly do Brasil Ltda. manufactures medicines. Its products include medicines for cancer, diabetes, depression, osteoporosis, and others. The company was founded in 1944 and is headquartered in Sao Paulo, Brazil. | Vorstandsvorsitzender | 01.01.1995 | 01.01.1999 |
| Präsident | 01.01.1995 | 01.01.1999 | |
| Eli Lilly Sweden AB | Vorstandsvorsitzender | 01.01.1993 | 01.01.1995 |
Ausbildung von Jacques Tapiero
| Thunderbird School of Global Management | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
| Spanien | 3 |
| Brasilien | 2 |
Operativ
| Chief Executive Officer | 3 |
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Non-Durables | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MCCORMICK & COMPANY, INCORPORATED | Consumer Non-Durables |
| Private Unternehmen | 5 |
|---|---|
Eli Lilly do Brasil Ltda.
Eli Lilly do Brasil Ltda. Pharmaceuticals: MajorHealth Technology Eli Lilly do Brasil Ltda. manufactures medicines. Its products include medicines for cancer, diabetes, depression, osteoporosis, and others. The company was founded in 1944 and is headquartered in Sao Paulo, Brazil. | Health Technology |
Lilly France SAS
Lilly France SAS Pharmaceuticals: GenericHealth Technology Lilly France SAS manufactures and supplies therapeutic products. The company is headquartered in Neuilly-sur-Seine, France. | Health Technology |
| Eli Lilly Sweden AB | |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
Esteve Healthcare SL
Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019. | Health Technology |
- Börse
- Insiders
- Jacques Tapiero
- Erfahrung
